Host: Robert J. Mentz, MD, FHFSA, FACC, FAHA Guest: Peter van der Meer, MD, PhD Iron deficiency is an extremely common comorbidity for 50% to 70% of our patients with heart failure in both the acute and chronic settings. It’s associated with poor e

Host: Jay Raman, MD, FACS Guest: Oguz Akin, MD Guest: Robert J. Motzer, MD Guest: Elizabeth Plimack, MD, MS Did you know that the current 5-year survival rate for patients diagnosed with metastatic RCC is only 12% despite advances in molecular

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Michelle Y. Owens, MD OB-GYN clinicians can improve how they communicate with their patients about hemolytic disease of the fetus and newborn or HDFN. Strategies include encouraging patients to talk abo

Host: George L. Bakris, MD Guest: Biykem Bozkurt, MD, PhD, FHFSA, FACC, FAHA, FACP Guest: Robert Toto, MD When treating patients with heart failure and chronic kidney disease, RAASi therapy should be continued if at all possible. One thing to kee

Host: Javed Butler, MD, MBA, MPH Guest: Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA It is well understood that RAASi therapy is critical in the management of patients with heart failure. However, hyperkalemia is common in these patients, and its pres

Guest: Maria E. Arcila, MD Guest: Alexander Drilon, MD Capitalizing on the advances in identification of oncogenic driver mutations, genetic testing, and therapeutic approaches that target actionable mutations, targeted therapy is the current stand

Guest: Michel Chonchol, MD Guest: Frederic Rahbari-Oskoui, MD, MS This Expert Exchange webcast aims to improve clinicians’ ability to manage patients diagnosed with ADPKD.

Guest: Cheryl Pirozzi, MD, MS Guest: Charlie Strange, MD Alpha-1 antitrypsin deficiency (AATD) is a common yet underdiagnosed genetic disorder. Led by 2 AATD experts, this activity will address the most current information on the screening, diagnos

Guest: Matthew B. Lanktree, MD, PhD Guest: Neera Dahl, MD, PhD This Expert Exchange webcast aims to improve clinicians’ ability to properly monitor disease progression and make treatment decisions based on prognostic indicators.

Guest: Arlene B. Chapman, MD Guest: Matthew B. Lanktree, MD, PhD This Expert Exchange webcast aims to improve clinicians’ ability to detect and diagnose ADPKD in at-risk patients.